Hematology and Oncology

Legislation mandating insurance coverage for breast cancer screening more impactful than breast density notification

Progression-free and overall survival significantly longer for patients with persistent, recurrent, metastatic cervical cancer

In seven of 22 cases, approval used new interpretations of original evidence and did not require new evidence

Overall, cancer responsible for loss of 1.9 percent of total life years expected in the absence of cancer in transplant recipients

Adults younger than 65 years twice as likely to report not filling needed prescriptions due to cost versus seniors

Compared with placebo, pembrolizumab prolonged regression-free survival in resected high-risk stage IIB and IIC melanoma

Reductions in mortality seen in association with ACE inhibitors, beta-blockers, thiazide diuretics

Removing race from CKD-EPI will calculate lower eGFR for Black patients and exclude more from receiving chemo

Stockholm3 of 0.11 or higher combined with MRI-targeted and systematic biopsies could detect significant cancers, reduce overdetection

Incidence among children, adolescents increased 0.5 to 0.7 percent; malignant tumor incidence highest for males, non-Hispanic Whites